MediTox
GLP-certified contract research organization (CRO) with 25+ years of experience in preclinical toxicology. Provides GLP-compliant nonclinical studies and supporting services for IND/registration of human drugs, biologicals and veterinary products, and biological evaluation of medical devices. Operates BSL‑2 facilities, conducts pharmacokinetic/pharmacodynamic studies and develops/validates disease models across rodent and non-rodent species (including dogs, cats, ferrets and mini‑pigs). Holds GLP certificates and national authorizations for animal work, GMO and controlled substance handling.
Industries
Nr. of Employees
medium (51-250)
MediTox
Konarovice, Stredocesky kraj, Czech Republic, Europe
Services
On-site execution of GLP single- and repeated-dose toxicology studies with TK endpoints for rodent and non-rodent species to support regulatory submissions.
Non-GLP exploratory studies including MTD, DRF, pilot and proof-of-concept studies to inform dosing and study design.
Target animal safety, bioequivalence, immersion/wash-out and environmental residue/wipe testing for veterinary products; experience with dogs and cats including cat-specific studies.
Biocompatibility testing for medical devices including systemic toxicity, irritation/sensitization and implantation studies aligned with MDR and ISO 10993 considerations.
Study-supporting pathology services including tissue processing, histological evaluation and clinical pathology analyses.
On-site execution of GLP single- and repeated-dose toxicology studies with TK endpoints for rodent and non-rodent species to support regulatory submissions.
Non-GLP exploratory studies including MTD, DRF, pilot and proof-of-concept studies to inform dosing and study design.
Target animal safety, bioequivalence, immersion/wash-out and environmental residue/wipe testing for veterinary products; experience with dogs and cats including cat-specific studies.
Biocompatibility testing for medical devices including systemic toxicity, irritation/sensitization and implantation studies aligned with MDR and ISO 10993 considerations.
Study-supporting pathology services including tissue processing, histological evaluation and clinical pathology analyses.
Expertise Areas
- Preclinical toxicology
- IND-enabling study execution
- Veterinary drug development and target animal safety
- Medical device biological evaluation
Key Technologies
- GLP-compliant toxicology studies
- Pharmacokinetic / pharmacodynamic (PK/PD/TK) assays
- Bioequivalence (BEQ) study design
- Disease model development (in vivo)
News & Updates
Planned attendance at multiple international industry events in 2026 including VET-EXPO, DeutcheVet, BIO International Convention, BioSpain, NLS Days, Bio-Europe Autumn and BioFIT.
Participation in Life Science Baltics 2025 for networking and partnership development in the life sciences sector.
Received co-funded support from an EU marketing program to participate in foreign events, strengthening international presence.
Involvement as a research partner in multiple European grant projects related to vaccine and biomaterial development.
Named participation in projects covering combined influenza/SARS vaccine development, live attenuated influenza vaccine development, a morphogenetic protein carrier device project, and universal influenza vaccine research.
Planned attendance at multiple international industry events in 2026 including VET-EXPO, DeutcheVet, BIO International Convention, BioSpain, NLS Days, Bio-Europe Autumn and BioFIT.
Participation in Life Science Baltics 2025 for networking and partnership development in the life sciences sector.
Received co-funded support from an EU marketing program to participate in foreign events, strengthening international presence.
Involvement as a research partner in multiple European grant projects related to vaccine and biomaterial development.
Named participation in projects covering combined influenza/SARS vaccine development, live attenuated influenza vaccine development, a morphogenetic protein carrier device project, and universal influenza vaccine research.